Meanwhile, AFP has been associated with liver cancer 30, and CEA is a broad-spectrum tumor marker used to assess the progression and prognosis of colorectal cancer 31, breast cancer 32, and lung cancer 33. This evidence concerns the gene AFP and breast carcinoma.